ReviewRSC advances2026
1,2,3-Triazole-linked DNA biosensors: molecular design to real-time applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many aspects of modern life rely on rapid, accurate, and selective detection methodologies, especially for heavy toxins, pathogens, biomolecules, metal ions, and miRNAs. Thus, there is a need for reliable and versatile advanced biosensing platforms that can meet these challenges. CuAAC-assisted systems have emerged as efficient tools for constructing DNA biosensors due to their high efficiency, bioorthogonality, and site-specific conjugation capabilities. This review highlights the role of copper(i)-catalyzed azide-alkyne cycloaddition (CuAAC) in DNA biosensing platforms. Emphasis is placed on the use of CuAAC-aided 1,2,3-triazoles for different linkages, surface modifications and dual-strand linkages. Furthermore, the integration of click chemistry with nanomaterials, DNA-based structures, DNAzymes, CRISPR, and ATRP for signal amplification and highly sensitive detection is discussed. Various signal transduction mechanisms are included, such as fluorescence, electroluminescence, and electrochemical signal outputs. In addition, the review evaluates recent discoveries, underlying mechanisms and current limitations, enabling a more in-depth understanding of how click chemistry is reforming DNA-based biosensing. Overall, this work underscores the power of 1,2,3-triazole to enhance next-generation biosensors with improved sensitivity, selectivity, and real-world applicability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.